(6-038) Cycling Tumor Necrosis Factor Inhibitors Versus Switching Mechanism of Action in Rheumatoid Arthritis Patients Who Previously Trialed Adalimumab at a Large Academic Medical Center
Tuesday, December 9, 2025
10:45 AM - 11:45 AM
Location: Bayside A, Level 1
Pharmacy School: University of North Carolina at Chapel Hill Eshelman School of Pharmacy Pharmacy School Location: North Carolina
